AzTrials
AzTrials

Out-of-hospital Cardiac Arrest (OHCA)TAPCAPNCT06672315

Application of Transesophageal Echocardiography in Pre-hospital Cardiac Arrest Patients

A study testing transesophageal echocardiography in people with Out-of-hospital Cardiac Arrest (OHCA), run by Jen-Tang Sun at 1 site in Taiwan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The Use of Point-of-Care Ultrasound (POCUS), Transthoracic Echocardiography (TTE), and Transesophageal Echocardiography (TEE) in Cardiac Arrest and Acute Coronary Syndrome Patients Studies have shown that POCUS can rapidly change the management in nearly 80% of cases in emergency settings, particularly in environments… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Out-of-hospital Cardiac Arrest (OHCA)
What is being tested?
transesophageal echocardiography
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTaiwan
Study dates
30 Dec 2024to 31 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years
  • Patients with out-of-hospital cardiac arrest (OHCA)
  • Non-traumatic cause of cardiac arrest

Who cannot join

  • Presence of obvious signs of death, such as decapitation, rigor mortis, livor mortis, or decomposition.
  • Family explicitly expresses a Do Not Attempt Resuscitation (DNR) order, or the patient has a documented refusal of resuscitation.
  • Any condition that contraindicates the use of transesophageal echocardiography (TEE), such as esophageal tumors, preventing probe insertion.
  • Patients eligible for ECPR (Extracorporeal Cardiopulmonary Resuscitation) treatment.
  • Spontaneous circulation has already been stabilized before performing TEE.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Taiwan1 site, 1 recruiting
  • Far Eastern Memorinal Hospital and New Taipei City fire department

    New Taipei City, 220

    Chiao-Yin Cheng Cheng, +886 2 7728 1843, femhresearch@gmail.com

    Recruiting

Other trials in Taiwan

About this study

Official title: Transesophageal Echocardiography in Pre-hospital Cardiac Arrest Patients; TAPCAP

The Use of Point-of-Care Ultrasound (POCUS), Transthoracic Echocardiography (TTE), and Transesophageal Echocardiography (TEE) in Cardiac Arrest and Acute Coronary Syndrome Patients

Studies have shown that POCUS can rapidly change the management in nearly 80% of cases in emergency settings, particularly in environments such as war zones and disaster relief. TTE is highly sensitive in diagnosing acute coronary syndromes and can effectively rule out myocardial infarction. In cardiac arrest patients, TTE assists in determining cardiac activity and identifying reversible causes, such as pericardial tamponade and pneumothorax. However, TTE can be affected by suboptimal image quality due to factors like chest compression in out-of-hospital cardiac arrest (OHCA) patients.

Read more

In Taiwan's emergency medical system, EMT-Ps (paramedics) undergo approximately one year of training, which enables them to provide emergency care, including ultrasound examinations, before hospital arrival. Research on pre-hospital cardiac arrest has shown that most ultrasound applications can be completed within 3 minutes and do not significantly increase on-scene time.

TEE, though advantageous for its high-quality imaging and ability to reduce interruptions during chest compressions, faces challenges in pre-hospital emergency applications due to specialized training and equipment requirements. However, a study in Vienna, Austria, demonstrated that TEE could be performed and yield high-quality images in most pre-hospital cases, with an average examination time of 5.1 minutes.

Several hospitals in Taiwan have begun training personnel in TEE, emphasizing the importance of establishing TEE image registries for large-scale, effective research analysis. However, these efforts also face challenges related to resources and collaboration. The research team has over three years of experience using TEE in the emergency department to examine OHCA patients, and a three-year study will be conducted to validate the efficacy of pre-hospital TEE in cardiac arrest patients.

Read the detailed description

Background:

The application of Point-of-Care Ultrasound (POCUS), Transthoracic Echocardiography (TTE), and Transesophageal Echocardiography (TEE) in cardiac arrest and acute coronary syndrome has evolved with technological advancements. POCUS, in particular, has been recognized for its ability to change clinical management in nearly 80% of emergency cases, such as war and disaster scenarios. TTE is highly sensitive in diagnosing acute coronary syndromes and can effectively rule out myocardial infarction. It also plays a crucial role in identifying reversible causes in cardiac arrest patients, like pericardial tamponade and pneumothorax, but its image quality can be compromised during chest compressions in out-of-hospital cardiac arrest (OHCA) patients. TEE, on the other hand, offers superior image quality and reduces interruptions during chest compressions but requires specialized training and equipment.

Currently, Taiwan\'s emergency medical system allows EMT-P personnel, after a year of training, to perform pre-hospital ultrasounds, including POCUS, for OHCA patients. Research has shown that most ultrasound applications can be completed in under 3 minutes without significantly increasing on-scene time. TEE\'s use in pre-hospital emergencies has also been validated in international studies, such as those from Vienna, which demonstrated TEE\'s feasibility in providing clear diagnostic images during pre-hospital cardiac arrest care.

Research Methods:

This study aims to assess the feasibility and efficacy of TEE in pre-hospital cardiac arrest care through a randomized controlled trial over three years.

Study Design:

The study will be conducted in two phases:

Phase 1: A prospective observational feasibility study involving 60 patients to assess the practical application of TEE in pre-hospital settings.

Patients aged 18 or older. Non-traumatic OHCA patients.

Exclusion Criteria:

Signs of obvious death. Patients with DNR orders. Patients for whom TEE is contraindicated (e.g., esophageal tumors). Patients requiring ECPR.

Training and Implementation:

Emergency department staff and EMT teams will undergo specialized training, including TEE workshops and simulations. The TEE procedure will be performed after establishing the airway and during mechanical chest compressions using a LUCAS device.

Data Collection:

Data will include patient demographics, emergency response times, CPR parameters, and TEE imaging results. Outcomes such as return of spontaneous circulation (ROSC) and neurological recovery will be tracked.

Randomization:

The RCT phase will utilize cluster randomization based on bi-weekly intervals, ensuring random and balanced patient groupings for intervention and control.

Sample Size Estimation:

Based on prior studies and statistical analysis, each group will require 93 patients to detect significant differences, with a total of 186 patients over the course of 24 months.

Expected Results:

The study anticipates that the use of TEE in pre-hospital cardiac arrest care will:

Provide high-quality cardiac images during CPR. Facilitate accurate identification of reversible causes of cardiac arrest. Improve the overall effectiveness of CPR through real-time feedback. Demonstrate the feasibility of integrating TEE into pre-hospital emergency protocols without significantly delaying patient transport.

The primary outcome is the proportion of cases where TEE ensures optimal chest compression. Secondary outcomes include the rate of sustained ROSC, time to ROSC, and neurological outcomes.

Conclusion:

This study will provide valuable insights into the feasibility and impact of TEE in pre-hospital cardiac arrest management. It will serve as the foundation for future large-scale research and contribute to improving survival rates and neurological outcomes in OHCA patients.

Being tested
transesophageal echocardiography
Keywords
Left Ventricular Outflow Tract, Transesophageal Echocardiography, TEE, LVOT, OHCA
Medical subject headings
Out-of-Hospital Cardiac Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • transesophageal echocardiographyDiagnostic test

    Confirmation of chest compression positioning via transesophageal echocardiography (TEE)

Study groups in NCT06672315
Study groupRoleWhat they receive
Performing TEEExperimentalIn this group of patients, transesophageal echocardiography (TEE) will be performed to confirm optimal chest compression positioning while utilizing a mechanical chest compression device.
Receives: Diagnostic Test: transesophageal echocardiography
not performing TEENo interventionIn this group of patients, transesophageal echocardiography (TEE) will not be performed, and the mechanical chest compression device will be positioned at the intersection of the nipple line and the sternum.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of using TEE to assist OHCA patients in pre-hospital emergency treatment

    Feasibility of using TEE to assist OHCA patients in pre-hospital emergency treatment. The proportion of successfully ensuring LV compression during prehospital CPR.

    Measured: 30 days after cardiac arrest or upon the patient's death, whichever came first

Secondary outcomes (5)
  1. Sustained return of spontaneous circulation (sustained ROSC) lasting approximately 20 minutes

    Measured: Patient sustained ROSC for 20 minutes after

  2. Time from the start of resuscitation to the first return of spontaneous circulation (ROSC)

    Time from the start of resuscitation to the first return of spontaneous circulation (ROSC)

    Measured: 1 minute after patient first ROSC

  3. Any ROSC rate

    Any ROSC rate

    Measured: 1 minute after patient ROSC

  4. Favorable neurologic outcome with discharge to home (Cerebral Performance Category 1 or 2)

    Record the patient's neurological outcome at the time of discharge

    Measured: Up to 6 months after discharge date

  5. End-tidal carbon dioxide (EtCO2)

    End-tidal carbon dioxide (EtCO2) values during the resuscitation process.

    Measured: One hour after arriving at the hospital

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Nov 2024
  2. Study start30 Dec 2024
  3. Primary completion31 Aug 2027 (estimated)
  4. Study completion31 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Model description
Patients aged 18 years or older who have experienced out-of-hospital cardiac arrest (OHCA) due to non-traumatic causes
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06672315
Sponsor's protocol ID
113027-F
Acronym
TAPCAP
Status last verified
Mar 2025
First submitted
30 Sep 2024
Last updated
5 Mar 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: Name and email

Publications

  • Krammel M, Hamp T, Hafner C, Magnet I, Poppe M, Marhofer P. Feasibility of resuscitative transesophageal echocardiography at out-of-hospital emergency scenes of cardiac arrest. Sci Rep. 2023 Nov 16;13(1):20085. doi: 10.1038/s41598-023-46684-x.

    PubMed 37973909
  • Hermann M, Hafner C, Scharner V, Hribersek M, Maleczek M, Schmid A, Schaden E, Willschke H, Hamp T. Remote real-time supervision of prehospital point-of-care ultrasound: a feasibility study. Scand J Trauma Resusc Emerg Med. 2022 Mar 24;30(1):23. doi: 10.1186/s13049-021-00985-0.

    PubMed 35331304
  • Reed MJ, Gibson L, Dewar A, Short S, Black P, Clegg GR. Introduction of paramedic led Echo in Life Support into the pre-hospital environment: The PUCA study. Resuscitation. 2017 Mar;112:65-69. doi: 10.1016/j.resuscitation.2016.09.003. Epub 2016 Sep 13.

    PubMed 27638418
  • Botker MT, Vang ML, Grofte T, Kirkegaard H, Frederiksen CA, Sloth E. Implementing point-of-care ultrasonography of the heart and lungs in an anesthesia department. Acta Anaesthesiol Scand. 2017 Feb;61(2):156-165. doi: 10.1111/aas.12847.

    PubMed 28066904
  • Clattenburg EJ, Wroe P, Brown S, Gardner K, Losonczy L, Singh A, Nagdev A. Point-of-care ultrasound use in patients with cardiac arrest is associated prolonged cardiopulmonary resuscitation pauses: A prospective cohort study. Resuscitation. 2018 Jan;122:65-68. doi: 10.1016/j.resuscitation.2017.11.056. Epub 2017 Nov 23.

    PubMed 29175356
  • Huis In 't Veld MA, Allison MG, Bostick DS, Fisher KR, Goloubeva OG, Witting MD, Winters ME. Ultrasound use during cardiopulmonary resuscitation is associated with delays in chest compressions. Resuscitation. 2017 Oct;119:95-98. doi: 10.1016/j.resuscitation.2017.07.021. Epub 2017 Jul 25.

    PubMed 28754527
  • El Sayed MJ, Zaghrini E. Prehospital emergency ultrasound: a review of current clinical applications, challenges, and future implications. Emerg Med Int. 2013;2013:531674. doi: 10.1155/2013/531674. Epub 2013 Sep 19.

    PubMed 24171113
  • Chin EJ, Chan CH, Mortazavi R, Anderson CL, Kahn CA, Summers S, Fox JC. A pilot study examining the viability of a Prehospital Assessment with UltraSound for Emergencies (PAUSE) protocol. J Emerg Med. 2013 Jan;44(1):142-9. doi: 10.1016/j.jemermed.2012.02.032. Epub 2012 May 16.

    PubMed 22595631
  • Hussein L, Rehman MA, Jelic T, Berdnikov A, Teran F, Richards S, Askin N, Jarman R; SHoC Investigators and the Resuscitative TEE Collaborative Registry Investigators. Transoesophageal echocardiography in cardiac arrest: A systematic review. Resuscitation. 2021 Nov;168:167-175. doi: 10.1016/j.resuscitation.2021.08.001. Epub 2021 Aug 12.

    PubMed 34390824
  • Breitkreutz R, Price S, Steiger HV, Seeger FH, Ilper H, Ackermann H, Rudolph M, Uddin S, Weigand MA, Muller E, Walcher F; Emergency Ultrasound Working Group of the Johann Wolfgang Goethe-University Hospital, Frankfurt am Main. Focused echocardiographic evaluation in life support and peri-resuscitation of emergency patients: a prospective trial. Resuscitation. 2010 Nov;81(11):1527-33. doi: 10.1016/j.resuscitation.2010.07.013.

    PubMed 20801576
  • Hayhurst C, Lebus C, Atkinson PR, Kendall R, Madan R, Talbot J, Ross P, Lewis D. An evaluation of echo in life support (ELS): is it feasible? What does it add? Emerg Med J. 2011 Feb;28(2):119-21. doi: 10.1136/emj.2009.084202. Epub 2010 Oct 4.

    PubMed 20921017
  • Long B, Alerhand S, Maliel K, Koyfman A. Echocardiography in cardiac arrest: An emergency medicine review. Am J Emerg Med. 2018 Mar;36(3):488-493. doi: 10.1016/j.ajem.2017.12.031. Epub 2017 Dec 16.

    PubMed 29269162
  • Rybicki FJ, Udelson JE, Peacock WF, Goldhaber SZ, Isselbacher EM, Kazerooni E, Kontos MC, Litt H, Woodard PK. 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force. J Am Coll Cardiol. 2016 Feb 23;67(7):853-79. doi: 10.1016/j.jacc.2015.09.011. Epub 2016 Jan 22. No abstract available.

    PubMed 26809772
  • Atkinson P, Bowra J, Milne J, Lewis D, Lambert M, Jarman B, Noble VE, Lamprecht H, Harris T, Connolly J; and members of the International Federation of Emergency Medicine Sonography in Hypotension and Cardiac Arrest working group: Romolo Gaspari, MD, PhD; Ross Kessler, MD; Christopher Raio, MD; Paul Sierzenski, MD; Beatrice Hoffmann, MD; Chau Pham, MD; Michael Woo, MD; Paul Olszynski, MD; Ryan Henneberry, MD; Oron Frenkel, MD; Jordan Chenkin, MD; Greg Hall, MD; Louise Rang, MD; Maxime Valois, MD; Chuck Wurster, MD; Mark Tutschka, MD; Rob Arntfield, MD; Jason Fischer, MD; Mark Tessaro, MD; J. Scott Bomann, DO; Adrian Goudie, MB; Gaby Blecher, MB; Andree Salter, MB; Michael Rose, MB; Adam Bystrzycki, MB; Shailesh Dass, MB; Owen Doran, MB; Ruth Large, MB; Hugo Poncia, MB; Alistair Murray, MB; Jan Sadewasser, MD; Raoul Breitkreutz, MD; Hong Chuen Toh, MB; Arif Alper Cevik, MD; Ang Shiang Hu, MB; Larry Melniker, MD, MS. International Federation for Emergency Medicine Consensus Statement: Sonography in hypotension and cardiac arrest (SHoC): An international consensus on the use of point of care ultrasound for undifferentiated hypotension and during cardiac arrest. CJEM. 2017 Nov;19(6):459-470. doi: 10.1017/cem.2016.394. Epub 2016 Dec 21.

    PubMed 27998322
  • Leonardi M, Condous G. A pictorial guide to the ultrasound identification and assessment of uterosacral ligaments in women with potential endometriosis. Australas J Ultrasound Med. 2019 Aug 9;22(3):157-164. doi: 10.1002/ajum.12178. eCollection 2019 Aug.

    PubMed 34760552

Questions about this trial

What is this clinical trial studying?

A study testing transesophageal echocardiography in people with Out-of-hospital Cardiac Arrest (OHCA), run by Jen-Tang Sun at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jen-Tang Sun (+886 2 77281843, femhresearch@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of using TEE to assist OHCA patients in pre-hospital emergency treatment (time frame: 30 days after cardiac arrest or upon the patient's death, whichever came first). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06672315, which also lists 18 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in